Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.

One in eight older adults experienced depression for the first time during the COVID-19 pandemic

Previous article

Staying Healthy In Retirement: Here Are 4 Valuable Tips

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News